IL10 and cancer: In addition to impairing the activation of cytotoxic T lymphocytes (CTLs) and Th1 CD4+ cells [22], IL10 inhibits the cytolytic activity of natural killer cells and CTLs [23], which are responsible for the immune surveillance of cancer.